Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical Trial

Author:

Karver Tahilin Sanchez12ORCID,Pascual-Bernaldez Miguel3,Berni Alessandro4,Hnoosh Ahmed5,Castagna Antonella6,Messiaen Peter78,Puerto Maria Jose Galindo9,Bloch Mark1011,Adachi Eisuke12,Sinclair Gary13,Felizarta Franco14,Angel Jonathan B.15,Sutton Kenneth16,Sutherland-Phillips Denise16,D'Amico Ronald16,Kerrigan Deanna1

Affiliation:

1. Department of Prevention and Community Health, The George Washington University Milken Institute School of Public Health, Washington, District of Columbia, USA.

2. Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

3. ViiV Healthcare, Madrid, Spain.

4. GlaxoSmithKline, West Uxbridge, United Kingdom.

5. Formerly with ViiV Healthcare, Brentford, United Kingdom.

6. IRCCS San Raffaele Hospital, Milan, Italy.

7. Department of Infectious Diseases and Immunity, Jessa Hospital, Hasselt, Belgium.

8. Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.

9. Universitat de València, Valencia, Spain.

10. Holdsworth House Medical Practice, and University of New South Wales, Sydney, Australia.

11. Department of Medicine, University of New South Wales, Sydney, Australia.

12. Department of Infectious Diseases and Applied Immunology, Hospital of the Institute of Medical Science, University of Tokyo, Tokyo, Japan.

13. PrismHealth North Texas, Dallas, Texas, USA.

14. Private Practice, Bakersfield, California, USA.

15. The Ottawa Hospital Research Institute, Ottawa, Canada.

16. ViiV Healthcare, Research Triangle Park, North Carolina, USA.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3